These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 38390696)

  • 21. How urban versus rural population relates to COVID-19 booster vaccine hesitancy: A propensity score matching design study.
    Miao Y; Bai J; Shen Z; Li Y; Zhang W; Zhu D; Ren R; Zhang J; Guo D; Tarimo CS; Dong W; Liu R; Zhao Q; Hu J; Li M; Wei W
    Hum Vaccin Immunother; 2024 Dec; 20(1):2297490. PubMed ID: 38214317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the impact of media and information on self-reported intentions to vaccinate against COVID-19: A qualitative interview-based study.
    Parsons Leigh J; Halperin D; Mizen SJ; FitzGerald EA; Moss SJ; Fiest KM; Di Castri A; Stelfox HT; Halperin S
    Hum Vaccin Immunother; 2022 Nov; 18(5):2048623. PubMed ID: 35417284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5-11 Years - United States, October 12-January 1, 2023.
    Hause AM; Marquez P; Zhang B; Su JR; Myers TR; Gee J; Panchanathan SS; Thompson D; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2023 Jan; 72(2):39-43. PubMed ID: 36634021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection - Increasing Community Access to Testing Program, United States, September-November 2022.
    Link-Gelles R; Ciesla AA; Fleming-Dutra KE; Smith ZR; Britton A; Wiegand RE; Miller JD; Accorsi EK; Schrag SJ; Verani JR; Shang N; Derado G; Pilishvili T
    MMWR Morb Mortal Wkly Rep; 2022 Dec; 71(48):1526-1530. PubMed ID: 36454688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety of monovalent and bivalent BNT162b2 mRNA COVID-19 vaccine boosters in at-risk populations in Israel: a large-scale, retrospective, self-controlled case series study.
    Yamin D; Yechezkel M; Arbel R; Beckenstein T; Sergienko R; Duskin-Bitan H; Yaron S; Peretz A; Netzer D; Shmueli E
    Lancet Infect Dis; 2023 Oct; 23(10):1130-1142. PubMed ID: 37352878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A qualitative insight into the perceptions and COVID-19 vaccine hesitancy among Pakistani pharmacists.
    Yaseen MO; Saif A; Khan TM; Yaseen M; Saif A; Bukhsh A; Shahid MN; Alsenani F; Tahir H; Ming LC; Amin MU; Suleiman AK; Al-Worafi YM; Baig MR; Saeed Imran M; Jaber AA
    Hum Vaccin Immunother; 2022 Dec; 18(1):2031455. PubMed ID: 35192781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 Antibody Responses to the Ancestral SARS-CoV-2 Strain and Omicron BA.1 and BA.4/BA.5 Variants in Nursing Home Residents After Receipt of Bivalent COVID-19 Vaccine - Ohio and Rhode Island, September-November 2022.
    Canaday DH; Oyebanji OA; White EM; Bosch J; Nugent C; Vishnepolskiy I; Abul Y; Didion EM; Paxitzis A; Sundheimer N; Ragavapuram V; Wilk D; Keresztesy D; Cao Y; St Denis K; McConeghy KW; McDonald LC; Jernigan JA; Mylonakis E; Wilson BM; King CL; Balazs AB; Gravenstein S
    MMWR Morb Mortal Wkly Rep; 2023 Jan; 72(4):100-106. PubMed ID: 36701254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 variants and the global pandemic challenged by vaccine uptake during the emergence of the Delta variant: A national survey seeking vaccine hesitancy causes.
    AlJamaan F; Temsah MH; Alhasan K; Alenezi S; Alhaboob A; Alrabiaah A; Batais M; Alshahrani F; Assiri RA; Bafaqih H; Alaraj A; Al Qadrah B; Alhaidary A; Saad K; Saddik B; Halwani R; Rabaan AA; Al-Subaie S; Barry M; Al-Tawfiq JA
    J Infect Public Health; 2022 Jul; 15(7):773-780. PubMed ID: 35728424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reasons for Receiving or Not Receiving Bivalent COVID-19 Booster Vaccinations Among Adults - United States, November 1-December 10, 2022.
    Sinclair AH; Taylor MK; Weitz JS; Beckett SJ; Samanez-Larkin GR
    MMWR Morb Mortal Wkly Rep; 2023 Jan; 72(3):73-75. PubMed ID: 36656784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A matter of trust: a qualitative comparison of the determinants of COVID-19 vaccine hesitancy in Taiwan, the United States, the Netherlands, and Haiti.
    Wang CW; de Jong EP; Faure JA; Ellington JL; Chen CS; Chan CC
    Hum Vaccin Immunother; 2022 Nov; 18(5):2050121. PubMed ID: 35349382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years - United States, August 31-October 23, 2022.
    Hause AM; Marquez P; Zhang B; Myers TR; Gee J; Su JR; Blanc PG; Thomas A; Thompson D; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2022 Nov; 71(44):1401-1406. PubMed ID: 36327162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trajectory of COVID-19 vaccine hesitancy post-vaccination and public's intention to take booster vaccines: A cross-sectional analysis.
    Salman M; Mallhi TH; Khan YH; Mustafa ZU; Khan MT; Khan FU; Butt MH; Shehzadi N; Farrukh MJ; Waheed M; Azmat F; Saeed A; Mazhar SA; Ali A; Ashfaq A; Hussain K
    Hum Vaccin Immunother; 2023 Aug; 19(2):2225990. PubMed ID: 37350298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines - United States, October 2022.
    Rosenblum HG; Wallace M; Godfrey M; Roper LE; Hall E; Fleming-Dutra KE; Link-Gelles R; Pilishvili T; Williams J; Moulia DL; Brooks O; Talbot HK; Lee GM; Bell BP; Daley MF; Meyer S; Oliver SE; Twentyman E
    MMWR Morb Mortal Wkly Rep; 2022 Nov; 71(45):1436-1441. PubMed ID: 36355612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 vaccine attitudes among a majority black sample in the Southern US: public health implications from a qualitative study.
    Huang W; Dove-Medows E; Shealey J; Sanchez K; Benson L; Seymore DD; Sullivan PS; Bradley HM; Siegler AJ
    BMC Public Health; 2023 Jan; 23(1):88. PubMed ID: 36631819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 vaccine booster dose hesitancy among key groups: A cross-sectional study.
    Huang M; He R; Chen Q; Song J; Huang H; Zheng S
    Hum Vaccin Immunother; 2023 Dec; 19(1):2166323. PubMed ID: 36951564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial.
    Mallory RM; Formica N; Pfeiffer S; Wilkinson B; Marcheschi A; Albert G; McFall H; Robinson M; Plested JS; Zhu M; Cloney-Clark S; Zhou B; Chau G; Robertson A; Maciejewski S; Hammond HL; Baracco L; Logue J; Frieman MB; Smith G; Patel N; Glenn GM;
    Lancet Infect Dis; 2022 Nov; 22(11):1565-1576. PubMed ID: 35963274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with the decision to receive bivalent COVID-19 booster vaccination among health care personnel.
    Mohr NM; Plumb ID; Santos León E; Harland KK; Krishnadasan A; Nandi U; Hoth KF; Smithline HA; Talan DA
    Hum Vaccin Immunother; 2023 Dec; 19(3):2284471. PubMed ID: 37994545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of a Second COVID-19 Vaccine Booster Dose Against Infection, Hospitalization, or Death Among Nursing Home Residents - 19 States, March 29-July 25, 2022.
    McConeghy KW; White EM; Blackman C; Santostefano CM; Lee Y; Rudolph JL; Canaday D; Zullo AR; Jernigan JA; Pilishvili T; Mor V; Gravenstein S
    MMWR Morb Mortal Wkly Rep; 2022 Sep; 71(39):1235-1238. PubMed ID: 36173757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccine Attitudes and COVID-19 Vaccine Intention Among Parents of Children With Kidney Disease or Primary Hypertension.
    Wang CS; Doma R; Westbrook AL; Johnson J; Anderson EJ; Greenbaum LA; Rana SA; George RP; Garro R; Khanna-Farber A; Escoffery C; Bednarczyk RA
    Am J Kidney Dis; 2023 Jan; 81(1):25-35.e1. PubMed ID: 35750280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Duration of protection of ancestral-strain monovalent vaccines and effectiveness of bivalent BA.1 boosters against COVID-19 hospitalisation in England: a test-negative case-control study.
    Kirsebom FCM; Andrews N; Stowe J; Ramsay M; Lopez Bernal J
    Lancet Infect Dis; 2023 Nov; 23(11):1235-1243. PubMed ID: 37453440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.